Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ayala Pharmaceuticals - 20 Year Stock Price History | ADXS

Historical daily share price chart and data for Ayala Pharmaceuticals since 2005 adjusted for splits and dividends. The latest closing stock price for Ayala Pharmaceuticals as of July 10, 2025 is 0.12.
  • The all-time high Ayala Pharmaceuticals stock closing price was 74999.60 on July 29, 2005.
  • The Ayala Pharmaceuticals 52-week high stock price is 0.78, which is 550% above the current share price.
  • The Ayala Pharmaceuticals 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Ayala Pharmaceuticals stock price for the last 52 weeks is 0.04.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ayala Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 0.0446 0.0270 0.1203 0.0270 0.1203 345.56%
2024 0.3015 0.6300 1.3100 0.0012 0.0270 -95.95%
2023 1.1614 1.3500 2.9500 0.5036 0.6670 -44.42%
2022 5.2179 13.5200 13.5200 1.0750 1.2000 -90.36%
2021 43.4507 33.3600 112.8000 11.7600 12.4480 -55.38%
2020 48.2957 87.2000 104.0000 22.7200 27.8960 -59.34%
2019 196.6216 353.9980 608.3970 19.8800 68.6160 -69.91%
2018 1799.0562 3719.9800 3887.9800 222.5990 227.9990 -93.31%
2017 7784.1733 8987.9600 11519.9000 3383.9800 3407.9800 -60.34%
2016 10751.9260 11291.9000 19175.9000 6551.9700 8591.9600 -28.83%
2015 17698.7108 10103.9000 34523.8000 8423.9600 12071.9000 25.59%
2014 4345.7466 4895.9800 10799.9000 3011.9800 9611.9500 88.92%
2013 7763.8466 4349.9800 20849.9000 3239.9800 5087.9700 13.07%
2012 14053.9039 23999.9000 25799.9000 4199.9800 4499.9800 -80.93%
2011 22367.2786 17999.9000 35549.8000 17249.9000 23594.9000 26.85%
2010 23610.7861 19499.9000 35249.8000 15149.9000 18599.9000 -8.15%
2009 12697.9614 2999.9900 26249.9000 2999.9900 20249.9000 575.00%
2008 12089.3391 24749.9000 24749.9000 1949.9900 2999.9900 -88.24%
2007 34418.1434 29999.8000 64499.7000 20999.9000 25499.9000 -5.56%
2006 32599.0841 31499.8000 44999.8000 20849.9000 26999.9000 -13.88%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.000B
Ayala Pharmaceuticals Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. It also involved in developing proprietary Lm-based antigen delivery products for patients suffering from more common cancers. The company's lead candidates under development are AL102 and ADXS-504. Ayala Pharmaceuticals Inc., formerly known as Advaxis Inc., is based in REHOVOT, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $77.043B 28.90
Zoetis (ZTS) United States $70.699B 26.38
Takeda Pharmaceutical (TAK) Japan $47.220B 9.39
Daiichi Sankyo, - (DSNKY) Japan $41.486B 21.26
BeOne Medicines - (ONC) Cayman Islands $27.772B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.640B 0.00
Summit Therapeutics (SMMT) United States $19.220B 0.00
Merck (MKKGY) Germany $17.273B 12.66
Shionogi (SGIOY) Japan $14.343B 14.37
United Therapeutics (UTHR) United States $13.539B 11.98
Neurocrine Biosciences (NBIX) United States $13.352B 45.74
Orion OYJ (ORINY) Finland $11.119B 30.07
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.856B 48.04
Corcept Therapeutics (CORT) United States $7.636B 62.08
Madrigal Pharmaceuticals (MDGL) United States $6.986B 0.00
Ionis Pharmaceuticals (IONS) United States $6.745B 0.00
Grifols, S.A (GRFS) Spain $6.704B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.048B 0.00
Hypermarcas (HYPMY) Brazil $3.182B 20.93
Crinetics Pharmaceuticals (CRNX) United States $2.995B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.665B 9.34
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.630B 14.22
NewAmsterdam Pharma (NAMS) Netherlands $2.472B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.957B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.858B 0.00
ARS Pharmaceuticals (SPRY) United States $1.766B 0.00
Ocular Therapeutix (OCUL) United States $1.765B 0.00
Endo (NDOI) United States $1.602B 0.00
ProKidney (PROK) United States $1.516B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
Guardian Pharmacy Services (GRDN) United States $1.319B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.206B 24.14
Harrow (HROW) United States $1.151B 0.00
Ardelyx (ARDX) United States $1.125B 0.00
Enliven Therapeutics (ELVN) United States $1.118B 0.00
Collegium Pharmaceutical (COLL) United States $1.060B 5.72
Akebia Therapeutics (AKBA) United States $1.045B 0.00
Dyne Therapeutics (DYN) United States $1.000B 0.00
Verve Therapeutics (VERV) United States $0.986B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.945B 0.00
Xeris Biopharma Holdings (XERS) United States $0.824B 0.00
Cronos Group (CRON) Canada $0.810B 0.00
KalVista Pharmaceuticals (KALV) United States $0.771B 0.00
Xencor (XNCR) United States $0.660B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.659B 0.00
Zevra Therapeutics (ZVRA) United States $0.657B 0.00
Relay Therapeutics (RLAY) United States $0.639B 0.00
USANA Health Sciences (USNA) United States $0.622B 13.53
Bioventus (BVS) United States $0.607B 15.40
Theravance Biopharma (TBPH) United States $0.573B 0.00
Organogenesis (ORGO) United States $0.558B 0.00
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Oruka Therapeutics (ORKA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.493B 10.30
Tourmaline Bio (TRML) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.400B 0.00
Savara (SVRA) United States $0.398B 0.00
Altimmune (ALT) United States $0.357B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.350B 9.47
Heron Therapeutics (HRTX) United States $0.339B 0.00
AleAnna (ANNA) United States $0.315B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.312B 0.00
Nektar Therapeutics (NKTR) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 26.52
Aldeyra Therapeutics (ALDX) United States $0.288B 0.00
OmniAb (OABI) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.247B 0.00
Esperion Therapeutics (ESPR) United States $0.246B 0.00
MediWound (MDWD) Israel $0.228B 0.00
Larimar Therapeutics (LRMR) United States $0.223B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.198B 0.00
Liminatus Pharma (LIMN) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Aclaris Therapeutics (ACRS) United States $0.172B 0.00
Journey Medical (DERM) United States $0.168B 0.00
Avita Medical (RCEL) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.152B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Lyell Immunopharma (LYEL) United States $0.145B 0.00
Korro Bio (KRRO) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Champions Oncology (CSBR) United States $0.122B 20.02
Protara Therapeutics (TARA) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Nutriband (NTRB) United States $0.091B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Achieve Life Sciences (ACHV) Canada $0.081B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.081B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Klotho Neurosciences (KLTO) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.072B 0.00
Dominari Holdings (DOMH) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Jupiter Neurosciences (JUNS) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.11
Iterum Therapeutics (ITRM) Ireland $0.043B 0.00
Karyopharm Therapeutics (KPTI) United States $0.043B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Vivos Therapeutics (VVOS) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.030B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 2.00
Talphera (TLPH) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00